Kroeger Christopher A. (CIK 1658918) reported 34 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-19). Recent activity: Buy MPLT (23,145 shares), Sell MPLT (18,950 shares), Sell MPLT (42,738 shares), Sell MPLT (90 shares), Sell MPLT (40,899 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-19 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Buy | 23,145 | $0 |
| 2026-07-17 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 18,950 | $682,200 |
| 2026-07-17 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 42,738 | $1.6M |
| 2026-07-17 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 90 | $3,379 |
| 2026-07-17 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 40,899 | $1.5M |
| 2026-07-17 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 28,091 | $1.0M |
| 2026-07-17 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 92 | $3,492 |
| 2026-07-17 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 16,779 | $635,924 |
| 2026-05-18 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 118,037 | $3.2M |
| 2026-05-18 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 198 | $5,574 |
| 2026-05-11 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 29,624 | $814,068 |
| 2026-05-11 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 5,220 | $152,163 |
| 2026-05-11 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 14,880 | $423,634 |
| 2026-05-11 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 1,582 | $45,182 |
| 2026-05-11 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 3,205 | $93,586 |
| 2026-05-11 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 342 | $9,429 |
| 2026-05-11 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 877 | $25,170 |
| 2026-05-11 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 6,871 | $206,405 |
| 2026-05-11 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 5,890 | $179,998 |
| 2026-05-06 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 9,136 | $251,240 |
| 2026-05-06 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 5,427 | $153,964 |
| 2026-05-06 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 311 | $9,193 |
| 2026-05-06 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 697 | $20,966 |
| 2026-05-06 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 9,544 | $268,377 |
| 2026-05-06 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 928 | $26,912 |
Source: SEC Form 4 filings · as of 2026-08-19